MARTIN CASTILLO: Open Payments
NPI 1588007249 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 42 payments from 10 companies in 2025. Trend: 2023 $702 · 2024 $542 · 2025 $793
Food & beverage: $788Education: $5
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 20 | $370 |
| ABBVIE INC. | 7 | $128 |
| Endo USA, Inc. | 4 | $63 |
| Boston Scientific Corporation | 2 | $53 |
| La Jolla Pharmaceutical Company | 2 | $47 |
| 180 Medical, Inc. | 2 | $39 |
| TOLMAR, INC. | 2 | $33 |
| COLOPLAST CORP | 1 | $25 |
| Astellas Pharma US Inc | 1 | $19 |
| UROGEN PHARMA, INC. | 1 | $17 |
Products named: GEMTESA, BOTOX, AMS 800 Artificial Urinary Sphincter, XIAFLEX, GIAPREZA, ELIGARD, Titan, GENTLECATH GLIDE.
Industry payments across LA — which companies pay providers there.
